🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the effectiveness of a simeprevir-...
Status
Completed
Location
Multiple Locations
Start Date
2014-02
Trial ID
NCT02103699
Treatments Being Tested
The purpose of the study is to evaluate the potential effect of TMC435 on t...
Status
Completed
Location
Multiple Locations
Start Date
2010-07
Trial ID
NCT01124799
Treatments Being Tested
The purpose of the study is to evaluate the efficacy and safety of a treatm...
Status
Completed
Location
Multiple Locations
Start Date
2014-04
Trial ID
NCT02114177
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of TMC64...
Status
Completed
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01202825
The purpose of this study is to show superiority of simeprevir (SMV) in com...
Status
Completed
Location
Multiple Locations
Start Date
2015-01
Trial ID
NCT02250807
Treatments Being Tested
A total of 201 participants with chronic HCV GT4 infection were allocated i...
Status
Completed
Location
Multiple Locations
Start Date
2015-04
Trial ID
NCT04385407
Treatments Being Tested
This is a study of the safety and effectiveness of the hepatitis C medicati...
Status
Withdrawn
Location
San Francisco General Hospital, University of California, San Francisco
Start Date
2014-08
Trial ID
NCT02206932
Treatments Being Tested
The purpose of this study is to compare absorption of TMC435 formulated as ...
Status
Completed
Location
Multiple Locations
Start Date
2011-03
Trial ID
NCT01308606
The purpose of this study is to evaluate the safety and tolerability of TMC...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01479868
Treatments Being Tested
The study aimed to present our experience in treating recurrent HCV genotyp...
Status
Completed
Location
Multiple Locations
Start Date
2014-09
Trial ID
NCT03133065
Treatments Being Tested